GeneDx

IPO

Empowering everyone to live their healthiest life through genomics

Public · Stamford · Founded 2000 · $1.0B raised

Headquarters
Stamford
Employees
501–1000
Founded
2000
Business Model
B2B
Website
genedx.com
Total Funding
$1.0B
Last Round
$200.0M Corporate RoundJan 2022
Rounds
3
Type
Public

About

GeneDx is a genomics company that provides comprehensive genetic testing for rare and undiagnosed conditions. Founded in 2000 by NIH scientists, GeneDx offers whole exome sequencing, whole genome sequencing, and targeted genetic panels to clinicians and patients worldwide. The company has diagnosed over 4,800 genetic diseases and published over 1,000 scientific papers. GeneDx trades on Nasdaq under the ticker WGS and is headquartered in Stamford, Connecticut.

Summary

GeneDx is a Biotech company based in Stamford, founded in 2000. It has raised $1.0B in total across 3 rounds, most recently a $200.0M Corporate Round round in Jan 2022. Investors include Blackstone, BlackRock and Section 32.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Debt FinancingDebt FacilityFeb 2026
$100.0M

Sign up to see all 4 rounds

Series C through Debt Financing — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

GeneDx on Indexed.vc
<a href="https://indexed.vc/companies/genedx"><img src="https://indexed.vc/api/badge/company/genedx" alt="GeneDx on Indexed.vc" width="260" height="76" /></a>